2024
ZFYVE21 promotes endothelial nitric oxide signaling and vascular barrier function in the kidney during aging
Jiang Q, Song G, He L, Li X, Jiang B, Wang Q, Wang S, Kim C, Barkestani M, Lopez R, Fan M, Wanniarachchi K, Quaranta M, Tian X, Mani A, Gonzalez A, Goodwin J, Sessa W, Ishibe S, Jane-Wit D. ZFYVE21 promotes endothelial nitric oxide signaling and vascular barrier function in the kidney during aging. Kidney International 2024, 106: 419-432. PMID: 38797325, PMCID: PMC11343665, DOI: 10.1016/j.kint.2024.05.007.Peer-Reviewed Original ResearchVascular barrier functionEndothelial cellsReduced endothelial nitric oxideRegulator of vascular barrier functionEndothelial nitric oxide signalingENOS activityEndosome-associated proteinsBarrier functionKidney organ culturesEndothelial nitric oxideAkt-dependent mannerNitric oxide donorGTPase Rab5Nitric oxide signalingZFYVE21Live cell imagingKidney insufficiencyReporter miceTrafficking mechanismsAccelerated aging phenotypeKnockout miceInterstitial edemaKidney functionVesicular populationOxide donor
1999
INHIBITION OF ANGIOGENESIS AND TUMOR GROWTH IN HUMAN PROSTATE CANCER LNCaP CELLS WITH THE INHIBITION OF ENDOTHELIAL NITRIC OXIDE
Moy Y, Sessa W, Weiss R. INHIBITION OF ANGIOGENESIS AND TUMOR GROWTH IN HUMAN PROSTATE CANCER LNCaP CELLS WITH THE INHIBITION OF ENDOTHELIAL NITRIC OXIDE. Journal Of Urology 1999, 161: 130.. DOI: 10.1097/00005392-199904010-00522.Peer-Reviewed Original Research